ArticleFrontiers in medicine2026
Epstein-Barr virus-associated retinitis: a case report.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: To report the clinical features, diagnostic workup, and management of Epstein-Barr virus (EBV)-associated retinitis in a patient without overt clinical evidence of severe immunodeficiency. Case description: A 33-year-old Chinese man presented with a 1-month history of blurred vision, redness, and photophobia in the left eye. Ocular examination revealed vitritis, white snowball-like vitreous deposits, optic disc edema, yellow-white retinal lesions, and tortuous retinal veins. Optical coherence tomography and fluorescein angiography supported active posterior segment inflammation. Initial vitreous smear and bacterial and fungal cultures were negative. Polymerase chain reaction testing of a vitreous sample detected EBV DNA at 123 copies/mL, whereas herpes simplex virus (HSV), varicella-zoster virus (VZV), and cytomegalovirus (CMV) were negative. The patient received systemic acyclovir combined with corticosteroid therapy. Intraocular inflammation improved markedly, but pars plana vitrectomy was later performed because of persistent organized vitreous opacity and retinal traction. At the 4-month follow-up, retinal lesions had largely resolved and best-corrected visual acuity improved to 0.2. Conclusion: This case suggests that EBV should be considered in the differential diagnosis of atypical infectious retinitis. Vitreous PCR may provide important etiological evidence, and timely combined medical and surgical management may contribute to a favorable outcome.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.